Autoimmune Disorders Research
13 comprehensive market analysis studies and research reports on the Autoimmune Disorders sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 121 companies, enriched with industry statistics, insights, and a lot more.

Healthcare
Categories
13 Healthcare Reports
Categories
Filters and Sort
Showing 13 of 13 results in Autoimmune Disorders
United States Rystiggo Drug Market
CAGR: 7.85%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:UCB
Starting at:$4,750
Rheumatology Therapeutics Market
CAGR: 2.08%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Abbvie, Johnson & Johnson, Amgen, Pfizer, Samsung Bioepis
Starting at:$4,750
Cutaneous Lupus Erythematosus Treatment Market
CAGR: 11.61%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:GlaxoSmithKline, AstraZeneca, Biogen, Leo Pharma, Sun Pharmaceuticals Industries
Starting at:$4,750
Graves Disease Market
CAGR: 4.92%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Abbott Laboratories, Roche, Horizon Therapeutics, Immunovant Inc., Pfizer
Starting at:$4,750
Systemic Lupus Erythematosus Market
CAGR: 7.5%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Eli Lilly and Company, Novartis, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline
Starting at:$4,750
Organ Transplant Immunosuppressant Drugs Market
CAGR: 4.48%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Astellas Pharma, Bristol-Myers Squibb, Novartis, Roche, Sanofi
Starting at:$4,750
Myasthenia Gravis Therapeutics Market
CAGR: 7.82%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:argenx SE, UCB, Johnson & Johnson, Novartis, AstraZeneca
Starting at:$4,750
Autoimmune Treatment Market
CAGR: 5.19%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Pfizer, Abbvie, Amgen, Johnson & Johnson, Eli Lilly and Company
Starting at:$4,750
Psoriatic Arthritis Therapeutics Market
CAGR: 5.74%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Abbvie, Johnson & Johnson, Pfizer, Sanofi, Bristol-Myers Squibb
Starting at:$4,750
Xerostomia (Dry Mouth Disease) Therapeutics Market
CAGR: 4.02%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Parnell Pharmaceuticals, Quest Healthcare, GlaxoSmithKline, Synedgen Inc., ADVANZ PHARMA Corp.
Starting at:$4,750
Alopecia Treatment (Hair Loss) Market
CAGR: 5.46%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Johnson & Johnson, Cipla, Merck, Pfizer, Eli Lilly and Company
Starting at:$4,750
Osteoarthritis Treatment Market
CAGR: 4.74%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, South America
Major Players:Sanofi, GlaxoSmithKline, Pfizer, Bayer, Zimmer Biomet
Starting at:$4,750
Rheumatoid Arthritis Drugs Market
CAGR: 4.51%
Study Period: 2020 - 2031
Starting at:$4,750
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Abbvie, Amgen, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb
Starting at:$4,750
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.












